Kalaris Therapeutics
NASDAQ: KLRS
$4.04
+0.01
(+0.25%)
as on
Kalaris Therapeutics Stock Performance
as on September 1, 2026 at 2:16 pm IST
Day's Low
Day's High
$3.83$4.02
5.20%
Downside
-0.50%
Upside
52 Week's Low
52 Week's High
$3.03$11.8825.00%
Downside
194.06%
Upside
Kalaris Therapeutics share price movements today
- Previous Close
- $4.03
- Open
- $3.99
- Volume
- 211.9K
- Market Cap
- $95.9M
- Day's Low - High
- $3.83 - $4.02
- 52 Week Low - High
- $3.03 - $11.88
Kalaris Therapeutics Historical Returns
- 1 Month Return
- + 14.81 %
- 3 Month Return
- -23.53 %
- 1 Year Return
- -1.23 %
- 3 Year Return
- 0 %
- 5 Year Return
- 0 %
Kalaris Therapeutics Stock Fundamentals & Key Indicators
Check Kalaris Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$95.9M
EPS (TTM)
-2.02
Dividend Yield
0.00%
PE Ratio (TTM)
-2.08
Industry PE ratio
-1.6496124031007753
PEG Ratio
-0.008810422068085771
Return On Equity TTM
-71.71%
Kalaris Therapeutics Stock Valuation
Track how Kalaris Therapeutics P/E has moved over time to understand its valuation trends.
Kalaris Therapeutics in the last 5 years
Lowest (-18.94x)
December 31, 2024
Today (-2.96x)
December 31, 2025
Industry (-1.65x)
December 31, 2025
Highest (-0.14x)
December 31, 2021
Today’s Price to Earnings Ratio: -2.96x
Kalaris Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Kalaris Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| StrongBuy | $95.9M | NA | -2.08 | 0.00% | NA | |
| BUY | $44.6B | 614.61% | NA | 0.00% | NA | |
| BUY | $137.2B | 170.45% | 31.92 | 86.04% | NA | |
| BUY | $55.1B | -63.37% | -7.98 | -12.57% | NA | |
| BUY | $85.8B | 17.94% | 19.9 | 84.86% | 0.44% |
Stock Returns calculator for Kalaris Therapeutics Stock including INR - Dollar returns
The Kalaris Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Kalaris Therapeutics investment value today
Current value as on today
₹1,06,827
Returns
₹6,827
(+6.83%)
Returns from Kalaris Therapeutics Stock
Dollar Impact
₹7,808 (+7.81%)
Analyst Recommendation on Kalaris Therapeutics Stock
Based on 4 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 4 analysts, 100% of analysts recommend a 'BUY' rating for Kalaris Therapeutics. Average target price of $15.5
Indian Investors' Interest in Kalaris Therapeutics Stock
Search interest for Kalaris Therapeutics Stock has decreased by -88% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Kalaris Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Kalaris Therapeutics Annual Profit & Loss
All numbers in Millions USD
Kalaris Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Kalaris Therapeutics Annual Cash Flow
All numbers in Millions USD
Insights on Kalaris Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 24.7% return, outperforming this stock by 119.2%
- NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 482.6% return, outperforming this stock by 483.6%
NEGATIVE IMPACTPrice Dip
In the last 6 months, KLRS stock has moved down by -61.4%
About Kalaris Therapeutics
| Organisation | Kalaris Therapeutics |
| Headquarters | 400 Connell Drive, Berkeley Heights, NJ, United States, 07922 |
| Industry | Biotechnology |
| CEO | Mr. Andrew Oxtoby |
| E-voting on shares | Click here to vote |
Key Management of Kalaris Therapeutics
Name | Title |
|---|---|
Ms. Amy Vandekop | Interim Principal Accounting Officer & Corporate Controller |
Ms. Kristine Curtiss | Senior Vice President of Clinical |
Mr. Andrew Oxtoby | President, CEO & Director |
Dr. Michael Philip Dybbs Ph.D. | Co-Founder & Director |
Dr. Napoleone Ferrara M.D. | Independent Director & Co-Founder |
Dr. Matthew Feinsod M.D. | Chief Medical Officer |
Ms. Liisa Ann Bayko M.B.A. | CFO & Treasurer |
Dr. Srinivas Akkaraju M.D., Ph.D. | Director & Co-Founder |
Dr. Jill E. Porter Ph.D. | Senior Vice President of CMC |
FAQs
What is Kalaris Therapeutics share price today?
Kalaris Therapeutics share price today is $4.04 as on at the close of the market. Kalaris Therapeutics share today touched a day high of $4.02 and a low of $3.83.
What is the 52 week high and 52 week low for Kalaris Therapeutics share?
Kalaris Therapeutics share touched a 52 week high of $11.88 on and a 52 week low of $3.03 on . Kalaris Therapeutics stock price today i.e. is closed at $4.04,which is 65.99% down from its 52 week high and 33.33% up from its 52 week low.
What is Kalaris Therapeutics's market capitalisation today?
Kalaris Therapeutics market capitalisation is $0.00T as on .
How to invest in Kalaris Therapeutics Stock (KLRS) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Kalaris Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kalaris Therapeutics Shares that will get you 0.3713 shares as per Kalaris Therapeutics share price of $4.04 per share as on September 1, 2026 at 8:46 am IST.
What is the minimum amount required to buy Kalaris Therapeutics Stock (KLRS) from India?
Indian investors can start investing in Kalaris Therapeutics (KLRS) shares with as little as ₹94.94 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Kalaris Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Kalaris Therapeutics share’s latest price of $4.04 as on September 1, 2026 at 8:46 am IST, you will get 2.4752 shares of Kalaris Therapeutics. Learn more about
fractional shares .